Lupus Trials News
The best and brightest are working toward finding better treatments and ultimately a cure for lupus. Read about how the most important influencers in the lupus community are effecting lupus research, along with other issues that matter most to you.
Lupus Research Alliance Appoints New Executive Vice President of Affiliate Lupus Therapeutics
NEW YORK, NY. January 17— The Lupus Research Alliance (LRA) is pleased to announce the appointment of Stacie J. Bell,...Read More
Promising Data Shows Lupus Research Alliance Peer Education Program Increases Intentions to Join Clinical Trials Among Diverse Patient Population
ACR Convergence 2022 Included LRA-Authored Research on Measures to Demonstrate Treatment Efficacy for Patients with Lupus NEW YORK, NY–November 8,...Read More
Lupkynis® (voclosporin) Granted Marketing Authorization in the European Union for Lupus Nephritis
September 21, 2022 Lupkynis® (voclosporin) was just granted marketing authorization in the European Union as a new treatment for adults...Read More
New England Journal of Medicine Publishes Positive Data of Litifilimab in Cutaneous Lupus Erythematosus
August, 2022 We are pleased to share positive results from the two-part Phase 2 LILAC study published in the New England...Read More
LRA Congratulates GSK on FDA Approval of Benlysta® (belimumab) for Children with Lupus Nephritis
NEW YORK, NY. July 27, 2022. The Lupus Research Alliance (LRA) is pleased to share that the U.S. Food and...Read More
Study Finds Booster Vaccine Significantly Lowered COVID-19 Infection Risk Among People with Lupus
July 14, 2022 The booster dose of the SARS-CoV-2 vaccine significantly enhanced the degree of protection from COVID-19 infections for...Read More
Lupus Research Alliance and Lupus Therapeutics Response to Positive Data from Phase 2 Study on Potential First-in-class Lupus Treatment
June 1, 2022 The Lupus Research Alliance (LRA) and its clinical trial arm Lupus Therapeutics congratulate Bristol Myers Squibb (BMS)...Read More
Jane Salmon, MD – Determined to Help Pregnant Women Triumph Over Lupus
March 24, 2022 Recognized for her contributions to lupus during 2022’s Women’s History Month, Dr. Jane Salmon chose to specialize...Read More
Judith James, MD, PhD Fulfills Childhood Dream to be a Doctor with Outstanding Career in Lupus Treatment and Research
March 14, 2022 Dr. Judith James has wanted to be a doctor since she was four years old. But it...Read More
Encouraging Results with Obinutuzumab for Lupus Nephritis
February 13, 2022 The LRA is pleased to share a recently published paper reporting that the drug, obinutuzumab, showed positive...Read More
Baricitinib Development as a Lupus Treatment Discontinued
January 28, 2022 The Lupus Research Alliance is disappointed that the Phase 3 development program of OLUMIANT® (baricitinib) as a...Read More
Lupus Research Alliance Launches Two Major Initiatives to Increase Participation of Underrepresented Minorities in Lupus Clinical Trials and Research
January 27, 2022 NEW YORK, NY. January 27 — The Lupus Research Alliance (LRA) and its clinical affiliate Lupus Therapeutics...Read More
FDA Authorizes Evusheld Emergency Use to Prevent COVID-19 in Immunocompromised Patients
December 9, 2021 People with lupus can be immunocompromised because of the disease itself or medications that suppress the immune...Read More
Aurinia Announces Positive Long-Term Results on Lupykinis™ for Lupus Nephritis
December 9, 2021 The LRA is pleased to share positive topline three-year efficacy and safety results reported today by Aurinia...Read More
Promise of Additional Lupus Therapies Highlighted at ACR 2021 Annual Meeting
November 9, 2021 Results of clinical trials testing many existing and potential lupus treatments were highlighted at the American College...Read More
A “Call to Arms” for the Lupus Community
August 18, 2021 Many lupus patients are at risk for COVID-19 infection because of treatment with corticosteroids and other immunosuppressive...Read More
Two Studies Show COVID-19 Vaccines are Well-Tolerated Among Lupus Patients
August 12, 2021 In two recent studies, researchers found that the four COVID-19 vaccines are well-tolerated in lupus patients. Given...Read More
Important Message from CEO Kenneth Farber: U.S. FDA Approves New Lupus Treatment
August 2, 2021 Dear Friend of the Lupus Research Alliance, As we reported this morning, the lupus community has much...Read More
Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca’s anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)
First in New Class of Drugs in More than a Decade for SLE Targeting Type 1 Interferons NEW YORK,...Read More
Two New Drugs Receive FDA Approval
May 1, 2021 “This is a historic moment in lupus with two new drug approvals for lupus nephritis just over...Read More
Lupus Expert Dr. Richard Furie Addresses Clinical Trials
June 12, 2019 As reported by The Rheumatologist, Dr. Richard Furie provided his perspective on clinical trials in lupus in...
Positive Early Results for BIIB059 as New Treatment Strategy
March 1, 2019 Proteins of the immune system, known as type I interferons, are responsible in part for manifestations of...
People with Lupus at Higher Risk for Bone Fractures, Study Shows
February 22, 2019 A study published in the peer-reviewed journal Arthritis & Rheumatology found that people with SLE and particularly...
Physical Fitness Associated with Health-related Quality of Life, Study Shows
February 22, 2019 Study results published in the peer-reviewed journal PLOS One showed that elements of physical fitness — muscle...
Study Shows Kidney Transplant Improves Lupus Nephritis Survival
A study just published in Annals of Internal Medicine showed that kidney transplantation reduced deaths due to lupus nephritis— kidney inflammation caused by lupus....
Study shows: Stress, Depression and Pain are Major Contributors to Lupus Fatigue
An observational study published in Lupus of people with lupus found that of six factors, stress, depression and pain contributed most to...
Existing Asthma Medication Shows Effectiveness for Lupus
A small randomized Phase 1 study published in Arthritis & Rheumatology found that the existing asthma treatment omalizumab (Xolair) may improve lupus...
New Trial Begins to Test Investigational Cenerimod to Treat Lupus
Source: Idorsia LTD Press Release Idorsia Ltd (SIX: IDIA) announced that the first patient has been enrolled into a multiple-dose study...
Poor Dental Care Associated with Lupus
A study just published in Clinical and Experimental Rheumatologyfound that exposure to periodontal bacteria on the gums around the teeth can...
Association Between Lupus and Cancer
A new analysis published in Arthritis Research & Therapy found that SLE is associated with increased risk of 16 cancers and decreased...